ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 51 - 60 of 89
Presenter(s): Dusty Jessen, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The provision of comprehensive auditory rehabilitation services is critical to successful patient outcomes, yet many audiologists focus primarily or exclusively on amplification due to time, reimbursement, and compliance challenges. This session will clearly define the components of auditory rehabilitation and provide specific strategies and tools to help overcome challenges.
Webinar product cover
Presenter(s): Derek J Stiles, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Congenital cytomegalovirus (cCMV) infection ranks among the leading causes of hearing loss in children. This live webinar (June 6, 2024, 3-4 p.m. ET)will explore the characteristics of cCMV and how it affects hearing, cognition, and movement as well as strategies for clinical care, advocacy, and public health as it relates to cCMV.
Presenter(s): Mary Beth Lannon, EdD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This recorded session from the ASHA Audiology 2022 Online Conference explores access to audiological services for individuals with intellectual disabilities. The speaker discusses testing adaptions, as well as training for students and professionals, that can maximize outcomes for these individuals. The session highlights the Special Olympics Healthy Athletes program as an example of a service that is successfully improving audiological evaluation and outcomes for individuals with intellectual disabilities.
Presenter(s): Mark A. Parker, PhD, CCC-A, F-AAA
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The audiogram is a poor representation of a person's underlying otopathology and can therefore be a poor predictor of a person's hearing impairment. For example, persons with audiometric thresholds within normal limits may experience hearing impairment such as difficulty hearing in noise. Cochlear synaptopathy and outer hair cell dysfunction are two otopathologies undetected by the standard audiogram (a.k.a. Hidden Hearing Loss), but outer hair cell function plays a primary role in hearing in noise performance. A third undetected otopathology is cochlear untuning, which occurs secondary to outer hair cell damage. This course discusses each of these otopathologies and presents clinical normative data that can be used to differentially diagnose each otopathology.
Presenter(s): David P Jedlicka, AuD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This on demand webinar discusses evaluation and treatment strategies for adults with self-perceived hearing concerns after a head injury, despite normal (or near normal) audiometric thresholds, with a focus on veterans. The webinar reviews comorbid conditions associated with self-perceived hearing difficulties and how treatment of the comorbidities can improve self-perceived hearing ability. The presenter discusses the current gaps and debates in the literature to highlight questions that need further exploration to provide the best, evidence-based hearing health care.
Presenter(s): Kimberly A Jenkins, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: In sensitive compartmented information facility (SCIF) environments, hearing aid features such as Bluetooth and bidirectional microphones—which allow seamless communication between hearing aids and communication devices—are considered security risks. This on demand webinar (available beginning March 16, 2024) will address considerations for hearing aids for patients who work in secure locations as well as share strategies currently being used by providers within the National Capital Region.
Presenter(s): Callie Niemann, BS; Lindsey E Jorgensen, AuD, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hearing aids are fit by audiologists based on audiometric data. However, features within the hearing aids, and accessories added to the hearing aids, can add to or detract from patient benefit. This recorded session from the ASHA Audiology 2022 Online Conference describes and demonstrates the need for-and methods of-verification of features and accessories for hearing aids.
Presenter(s): A.U. Bankaitis, PhD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Medical professionals who use hearing aids can face challenges when they need to perform auscultation (listening to sounds from various organs, most often with a stethoscope) as part of their job. While the options may not seem straightforward, audiologists can play a key role in helping these medical professionals find an amplified stethoscope solution. This on demand webinar (available beginning March 21, 2024) will discuss key considerations, potential options, and practical steps for helping medical professionals with hearing loss obtain the best solution.
Credit(s): PDHs: 3.0, ASHA CEUs*: 0.3
Summary: This journal self-study focuses on several aspects of patient care and management for practitioners who serve children who are deaf or hard of hearing. The articles, originally published in a 2014 issue of Perspectives on Hearing and Hearing Disorders in Childhood, discuss the unique needs of children with mild, minimal, and/or unilateral hearing loss; the effects of fatigue on children with hearing loss; and the importance of monitoring speech-language performance and progress as well as hearing aid use in this population.
Presenter(s): Victoria A Sanchez, AuD, PhD, CCC-A, F-AAA; Ann Clock Eddins, PhD, MBA, CCC-A, FAAA
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Emerging treatment approaches for age-related hearing loss include alternative interventions aimed at ameliorating symptoms and slowing down or even preventing hearing loss, in contrast with current treatment approaches, which focus primarily on amplification and communication strategies. This session will explore up-and-coming approaches, such as pre-clinical investigation of hormones (e.g., Aldosterone) correlated with auditory function; medicinal-related interventions; and challenges to timelines to bring new treatments to market.
<< 1 2 3 4 5 6 7 8 9 >>